Skip to main content
. 2019 Nov 3;33(6):2153–2160. doi: 10.21873/invivo.11717

Table II. Patient background (treatment modifications).

graphic file with name in_vivo-33-2156-i0001.jpg

CI: Confidence intervaI; IQR: interquartile range; MSKCC: Memorial Sloan Kettering Cancer Center. *Clear-cell carcinoma vs. non-clear-cell carcinoma. **≥37.5 vs. <37.5 mg.